Hoth Therapeutics (HOTH)
(Delayed Data from NSDQ)
$0.86 USD
-0.05 (-5.84%)
Updated Sep 24, 2024 04:00 PM ET
After-Market: $0.85 -0.01 (-1.16%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth A Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/11/2024
Time: -- |
9/2024 | $-0.30 | 0.00% |
Earnings Summary
For their last quarter, Hoth Therapeutics (HOTH) reported earnings of -$0.24 per share, beating the Zacks Consensus Estimate of $-0.39 per share. This reflects a positive earnings surprise of 38.46%. Look out for HOTH's next earnings release expected on November 11, 2024. For the next earning release, we expect the company to report earnings of -$0.30 per share, reflecting a year-over-year increase of 50%.
Earnings History
Price & Consensus
Zacks News for HOTH
Hoth Therapeutics (HOTH) Up on Upbeat Alzheimer's Drug Data
HOTH: What are Zacks experts saying now?
Zacks Private Portfolio Services